11/25
01:49 pm
coll
Collegium Pharmaceutical (NASDAQ:COLL) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Collegium Pharmaceutical (NASDAQ:COLL) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
11/25
07:31 am
coll
Collegium Pharmaceutical (NASDAQ:COLL) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Collegium Pharmaceutical (NASDAQ:COLL) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
11/20
05:43 am
coll
Collegium (COLL) Raises 2025 Revenue Guidance—Is Profitability Momentum Built to Last? [Yahoo! Finance]
Low
Report
Collegium (COLL) Raises 2025 Revenue Guidance—Is Profitability Momentum Built to Last? [Yahoo! Finance]
11/19
01:17 pm
coll
Collegium Pharmaceutical (NASDAQ:COLL) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Collegium Pharmaceutical (NASDAQ:COLL) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
11/12
08:48 am
coll
Collegium to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Collegium to Participate in Upcoming Investor Conferences [Yahoo! Finance]
11/12
08:00 am
coll
Collegium to Participate in Upcoming Investor Conferences
Medium
Report
Collegium to Participate in Upcoming Investor Conferences
11/11
09:26 am
coll
2 Momentum Stocks with Exciting Potential and 1 We Find Risky [Yahoo! Finance]
Low
Report
2 Momentum Stocks with Exciting Potential and 1 We Find Risky [Yahoo! Finance]
11/10
04:28 pm
coll
Collegium Pharmaceutical: Another Solid Quarter [Seeking Alpha]
Medium
Report
Collegium Pharmaceutical: Another Solid Quarter [Seeking Alpha]
11/8
10:14 pm
coll
Organon (OGN) Reports Earnings Tomorrow: What To Expect [Yahoo! Finance]
Low
Report
Organon (OGN) Reports Earnings Tomorrow: What To Expect [Yahoo! Finance]
11/8
07:05 pm
coll
A Look at Collegium Pharmaceutical's (COLL) Valuation After Upbeat Q3 Results and Raised Guidance [Yahoo! Finance]
Low
Report
A Look at Collegium Pharmaceutical's (COLL) Valuation After Upbeat Q3 Results and Raised Guidance [Yahoo! Finance]
11/7
11:09 am
coll
Collegium Pharmaceutical (NASDAQ:COLL) had its price target raised by analysts at Truist Financial Corporation from $45.00 to $48.00. They now have a "buy" rating on the stock.
Low
Report
Collegium Pharmaceutical (NASDAQ:COLL) had its price target raised by analysts at Truist Financial Corporation from $45.00 to $48.00. They now have a "buy" rating on the stock.
11/7
10:26 am
coll
COLL Q3 Deep Dive: Jornay PM Momentum and Pain Portfolio Drive Upgraded Outlook [Yahoo! Finance]
Low
Report
COLL Q3 Deep Dive: Jornay PM Momentum and Pain Portfolio Drive Upgraded Outlook [Yahoo! Finance]
11/7
08:07 am
coll
Collegium Pharmaceutical (NASDAQ:COLL) had its price target raised by analysts at HC Wainwright from $44.00 to $46.00. They now have a "buy" rating on the stock.
Medium
Report
Collegium Pharmaceutical (NASDAQ:COLL) had its price target raised by analysts at HC Wainwright from $44.00 to $46.00. They now have a "buy" rating on the stock.
11/6
07:30 am
coll
Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance
Medium
Report
Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance
10/29
08:00 am
coll
Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment
Medium
Report
Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment
10/28
08:09 am
coll
Collegium Pharmaceutical (NASDAQ:COLL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $46.00 price target on the stock.
Low
Report
Collegium Pharmaceutical (NASDAQ:COLL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $46.00 price target on the stock.
10/25
07:36 am
coll
Collegium Pharmaceutical (COLL): Assessing Valuation After Recent Share Price Momentum [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical (COLL): Assessing Valuation After Recent Share Price Momentum [Yahoo! Finance]
10/25
07:11 am
coll
Collegium Pharmaceutical (NASDAQ:COLL) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
Collegium Pharmaceutical (NASDAQ:COLL) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
10/23
08:00 am
coll
Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025
Low
Report
Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025
10/22
08:00 am
coll
Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences
Low
Report
Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences
10/13
08:26 am
coll
Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing [Yahoo! Finance]
Low
Report
Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing [Yahoo! Finance]
10/13
08:00 am
coll
Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing
Low
Report
Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing
10/10
04:03 pm
coll
UnitedHealth, Brookdale, Collegium Pharmaceutical, QuidelOrtho, and Biogen Shares Are Falling, What You Need To Know [Yahoo! Finance]
Low
Report
UnitedHealth, Brookdale, Collegium Pharmaceutical, QuidelOrtho, and Biogen Shares Are Falling, What You Need To Know [Yahoo! Finance]
10/8
11:42 am
coll
Collegium Pharmaceutical, Inc. (COLL): A Bull Case Theory [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical, Inc. (COLL): A Bull Case Theory [Yahoo! Finance]
10/1
07:04 am
coll
Does Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Create Value For Shareholders? [Yahoo! Finance]
Low
Report
Does Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Create Value For Shareholders? [Yahoo! Finance]